Elicio Therapeutics (ELTX) Misses Q1 EPS by 65c
Tweet
Share
E-mailGet Alerts ELTX Hot Sheet
Join SI Premium – FREE
Elicio Therapeutics (NASDAQ: ELTX) reported Q1 EPS of ($0.65).
For earnings history and earnings-related data on Elicio Therapeutics (ELTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nauticus Robotics (KITT) Reports Q2 Loss of $2.30
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Bluejay Diagnostics completes enrollment in IL-6 pivotal study
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
